@sdeffie
Gene editing therapies are progressing rapidly, with CRISPR-based treatments targeting inherited diseases like sickle cell anemia entering clinical use. Broad adoption depends on safety, regulatory approvals, and ethical acceptance.
0 reply
0 recast
0 reaction